Harvest Fund Management Co., LTD Gilead Sciences, Inc. Transaction History
Harvest Fund Management Co., LTD
- $2.35 Billion
- Q3 2025
A detailed history of Harvest Fund Management Co., LTD transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Harvest Fund Management Co., LTD holds 93,141 shares of GILD stock, worth $11.6 Million. This represents 0.44% of its overall portfolio holdings.
Number of Shares
93,141
Previous 86,595
7.56%
Holding current value
$11.6 Million
Previous $9.6 Million
7.69%
% of portfolio
0.44%
Previous 0.46%
Shares
23 transactions
Others Institutions Holding GILD
# of Institutions
2,369Shares Held
1.01BCall Options Held
8.58MPut Options Held
7.35M-
Black Rock Inc. New York, NY121MShares$15 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.8 Billion0.21% of portfolio
-
State Street Corp Boston, MA59.1MShares$7.33 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA45.2MShares$5.61 Billion0.72% of portfolio
-
Dodge & Cox San Francisco, CA30.1MShares$3.74 Billion1.93% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $156B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...